Dr. Dongxu Sun, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2001 N Jefferson Ave, Mt Pleasant, TX 75455 Phone: 903-577-6000 |
News Archive
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
A study published in the latest issue of Journal of Personality finds that when people feel an event has had a large impact on them, e.g. it contributed to their life story or sense of identity, they downplay the negative and emphasize the positive.
Although brains—even adult brains—are far more malleable than we used to think, they are eventually subject to age-related illnesses, like dementia, and loss of cognitive function.
A PLoS Neglected Tropical Diseases study found how a new drug developed by scientists in China effectively kills roundworms – "a parasite that lurks in the intestines and which affects nearly two billion people in tropical countries," Reuters reports. "Roundworms are particularly harmful to children and pregnant women," Reuters writes.
Comorbid attention-deficit hyperactivity disorder is common in patients with bipolar disorder (BD), and is associated with more mixed states, more severe psychopathology, and more impaired family functioning, Italian researchers report.
› Verified 4 days ago